MOG and myeloid sarcoma: Given that anti-MBP and anti-MOG autoantibodies are thought to be implicated in demyelination, we evaluated the effects of EVs containing anti-MBP and anti-MOG autoantibodies from patients with MS on myelin markers in vitro.